CANNABIS
Brandon Romanek
Founder & CEO,
THC Therapeutics
Follow
About Brandon
Brandon Romanek has over 20 years of experience in managing healthcare business and over 15 years of experience in money management, trading/investing of stocks, options and commodities. He has led the formation of THC Therapeutics to become a publicly traded company, with an experienced management team to ramp up sales for the proprietary new market category technologies. Mr. Romanek is passionate about growing the company in the cannabis industry by seeking mergers and acquisitions of other cannabis and related holistic care businesses.
Brandon's Videos
The legal cannabis movement scored its most significant victory in 2016 as voters in California, Massachusetts and Nevada approved state ballot measures that legalized recreational cannabis while voters in Florida, North Dakota and Arkansas approved ballot measures that legalized medical cannabis. The 2016 election changed the landscape of the cannabis industry this panel of experts features executives from cannabis companies that are capitalizing on the United States cannabis industry.
We're a brand new publicly traded cannabis company, and we're off to a great start. It's been 4 months since we launched and we've already completed our first of many mergers and acquisitions, received phenomenal testing results on our flagship product the dHydronatorand hired Dr. John Pierce to head the medical side of our company. We'd like to introduce ourselves as well as our product and share our perspective on this emerging sector. The keys to building our company, beside our flagship product, is by doing major acquisitions in the health and wellness/cannabis industries.